KEPODIL-CV DRY SYRUPAugust 1, 2015
KEPODIL-CV is effective in the treatment of infections caused by penicillinase-producing strains of bacteria.
KEPODIL-CV has a broad spectrum activity as clavulanic acid extends the spectrum of antibiotics to b-lactamase producing microorganisms.
Cefopodoxime: 3rd generation oral cephalosporin
ClavulanicAcid: beta-lactamase inhibitor
MODE OF ACTION:
> Cefpodoxime:Cefpodoxime kills bacteria by inhibiting cell wall synthesis by binding to target proteins.
> Clavulanicacid:Inhibit beta-lactamase enzyme and is used in combination to extend the anti-bacterial spectrum.
Post-surgicalinfection Typhoid fever
RespiratoryTractInfections UrinaryTract Infections
Adult dose: 1 Tab. (KEPODIL CV-200) 2 times in a day for 5-10 days.
Paediatric dose: 8-10mg / kg / day in two divided doses on the basis of Cefpodoxime content.
Pregnancy : Can be given.
Lactation : Given with caution.
Geriatrics : Can be given safely.
Contraindications: Hypersensitivity reactions to penicillin, cephalosporins and other beta-lactam antibiotics, beta-lactamase inhibitors or any excipient used in the formulations.
Precautions: Caution advised in patients receiving diuretics concurrently.
Adverse effects: Diarrheoa, nausea, vaginal fungal infections, vomiting, headache.